Published in J Infect Dis on February 01, 1986
Respiratory syncytial virus infection in adults. Clin Microbiol Rev (2000) 3.16
Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function. J Virol (1989) 2.59
Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity. J Virol (1987) 2.26
Respiratory syncytial virus genetic and antigenic diversity. Clin Microbiol Rev (2000) 2.07
Molecular characterization of circulating respiratory syncytial virus (RSV) genotypes in Gilgit Baltistan Province of Pakistan during 2011-2012 winter season. PLoS One (2013) 2.06
Subgroup characteristics of respiratory syncytial virus strains recovered from children with two consecutive infections. J Clin Microbiol (1987) 2.06
Biological challenges and technological opportunities for respiratory syncytial virus vaccine development. Immunol Rev (2011) 2.04
Detection, pathogenesis, and therapy of respiratory syncytial virus infections. Clin Microbiol Rev (1988) 1.92
Comparison of two new tests for rapid diagnosis of respiratory syncytial virus infections by enzyme-linked immunosorbent assay and immunofluorescence techniques. J Clin Microbiol (1986) 1.61
Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus. Am J Pathol (2006) 1.55
Emerging genotypes of human respiratory syncytial virus subgroup A among patients in Japan. J Clin Microbiol (2009) 1.44
Subgroup prevalence and genotype circulation patterns of human respiratory syncytial virus in Belgium during ten successive epidemic seasons. J Clin Microbiol (2007) 1.39
Molecular epidemiology of respiratory syncytial virus infections among children with acute respiratory symptoms in a community over three seasons. J Clin Microbiol (2005) 1.28
New genotypes within respiratory syncytial virus group B genotype BA in Niigata, Japan. J Clin Microbiol (2010) 1.27
Analysis of respiratory syncytial virus genetic variability with amplified cDNAs. J Clin Microbiol (1993) 1.25
Genetic variability of group A human respiratory syncytial virus strains circulating in Germany from 1998 to 2007. J Clin Microbiol (2009) 1.21
Occurrence of respiratory syncytial virus subgroup A and B strains in Japan, 1980 to 1987. J Clin Microbiol (1988) 1.20
Nosocomial transmission of respiratory syncytial virus in immunocompromised adults. J Clin Microbiol (1991) 1.09
RNA fingerprinting of respiratory syncytial virus using ribonuclease protection. Application to molecular epidemiology. J Clin Invest (1989) 1.03
Differentiation of respiratory syncytial virus subgroups with cDNA probes in a nucleic acid hybridization assay. J Clin Microbiol (1990) 1.02
Synthetic oligonucleotide probes differentiate respiratory syncytial virus subgroups in a nucleic acid hybridization assay. J Clin Microbiol (1991) 0.98
Antigenic characterization of respiratory syncytial virus associated with acute respiratory infections in Uruguayan children from 1985 to 1987. J Clin Microbiol (1989) 0.93
Molecular epidemiology and disease severity of human respiratory syncytial virus in Vietnam. PLoS One (2013) 0.93
Prevalence of respiratory syncytial virus subgroups A and B in France from 1982 to 1990. J Clin Microbiol (1991) 0.91
Genetic variability among Group A and B respiratory syncytial virus isolates from a large referral hospital in New Delhi, India. J Clin Microbiol (2003) 0.91
Antigenic characterization of respiratory syncytial virus group A and B isolates in Rio de Janeiro, Brazil. J Clin Microbiol (1991) 0.88
High frequency of repeated infections due to emerging genotypes of human respiratory syncytial viruses among children during eight successive epidemic seasons in Japan. J Clin Microbiol (2010) 0.88
Respiratory syncytial virus and the infant immune response. Arch Dis Child (1987) 0.87
G protein variation in respiratory syncytial virus group A does not correlate with clinical severity. J Clin Microbiol (2000) 0.86
Frequent Asymptomatic Respiratory Syncytial Virus Infections During an Epidemic in a Rural Kenyan Household Cohort. J Infect Dis (2015) 0.80
Identification of subgroups of bovine respiratory syncytial virus. J Clin Microbiol (1992) 0.79
Spatiotemporal patterns of infant bronchiolitis in a Tennessee Medicaid population. Spat Spatiotemporal Epidemiol (2013) 0.79
Epidemiological changes of respiratory syncytial virus (RSV) infections in Israel. PLoS One (2014) 0.78
Development of a luciferase immunoprecipitation system assay to detect IgG antibodies against human respiratory syncytial virus nucleoprotein. Clin Vaccine Immunol (2014) 0.78
GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion Process. Antimicrob Agents Chemother (2015) 0.78
Infections due to respiratory syncytial virus in Canada. CMAJ (1987) 0.77
Genetic variability and molecular epidemiology of respiratory syncytial virus subgroup a strains in Japan determined by heteroduplex mobility assay. J Clin Microbiol (2004) 0.77
Mammalian Cell-Derived Respiratory Syncytial Virus-Like Particles Protect the Lower as well as the Upper Respiratory Tract. PLoS One (2015) 0.76
Epidemiology and Clinical Presentations of Respiratory Syncytial Virus Subgroups A and B Detected with Multiplex Real-Time PCR. PLoS One (2016) 0.75
Clinical characterisation and phylogeny of respiratory syncytial virus infection in hospitalised children at Red Cross War Memorial Children's Hospital, Cape Town. BMC Infect Dis (2016) 0.75
Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science (1994) 13.54
Nipah virus: a recently emergent deadly paramyxovirus. Science (2000) 9.39
Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA (1999) 8.07
Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol (2000) 7.78
Evolution and transmission of stable CTL escape mutations in HIV infection. Nature (2001) 6.57
Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med (2010) 6.38
Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J Infect Dis (1985) 5.91
Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin Infect Dis (2000) 4.82
The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic children. J Pediatr (1973) 4.22
A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. N Engl J Med (2000) 4.14
Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis (2006) 3.59
Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells. Nature (1989) 3.54
Detection of respiratory syncytial virus in nasal secretions from infants by enzyme-linked immunosorbent assay. J Infect Dis (1979) 3.49
Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease. Proc Natl Acad Sci U S A (1967) 3.47
Myopathies associated with human immunodeficiency virus and zidovudine: can their effects be distinguished? Neurology (1993) 3.35
Enterovirus 71 infections and neurologic disease--United States, 1977-1991. J Infect Dis (1994) 3.31
Monoclonal antibodies protect against respiratory syncytial virus infection in mice. Immunology (1984) 3.27
Enzyme-linked immunosorbent assay for detection of respiratory syncytial virus infection: application to clinical samples. J Clin Microbiol (1982) 3.22
Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community. J Gen Virol (1998) 3.06
Temporal and geographic patterns of isolates of nonpolio enterovirus in the United States, 1970-1983. J Infect Dis (1986) 3.01
Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation (2009) 2.85
Chronic fatigue in general practice: is counselling as good as cognitive behaviour therapy? A UK randomised trial. Br J Gen Pract (2001) 2.76
A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Invest (1989) 2.71
Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. J Virol (2001) 2.70
Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. J Infect Dis (2000) 2.68
Molecular characterization of Nipah virus, a newly emergent paramyxovirus. Virology (2000) 2.63
Immunochemical identification of viral and nonviral proteins of the respiratory syncytial virus virion. Infect Immun (1982) 2.61
Case-control study of risk factors for human infection with a new zoonotic paramyxovirus, Nipah virus, during a 1998-1999 outbreak of severe encephalitis in Malaysia. J Infect Dis (2000) 2.57
Coronavirus infection in acute lower respiratory tract disease of infants. J Infect Dis (1974) 2.55
Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions. Proc Natl Acad Sci U S A (1991) 2.55
Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. J Infect Dis (1996) 2.55
Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group. N Engl J Med (1999) 2.51
Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J Infect Dis (1999) 2.44
Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children. J Infect Dis (1990) 2.41
The immunologic response to infection with respiratory syncytial virus in infants. J Infect Dis (1978) 2.32
Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children. J Exp Med (2000) 2.31
Detection of Norwalk virus antibodies and antigen with a biotin-avidin immunoassay. J Clin Microbiol (1985) 2.28
Viral and bacterial infections in adults with chronic asthma. Am Rev Respir Dis (1979) 2.25
Mutational analysis of the leucine zipper-like motif of the human immunodeficiency virus type 1 envelope transmembrane glycoprotein. J Virol (1993) 2.21
CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nat Immunol (2001) 2.21
Genetic diversity of the attachment protein of subgroup B respiratory syncytial viruses. J Virol (1991) 2.14
Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America. J Infect Dis (2000) 2.13
A comparative study of virus isolation, polymerase chain reaction, and antigen detection in children of mothers infected with human immunodeficiency virus. J Pediatr (1990) 2.09
Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity. J Pediatr (1980) 2.07
Coronaviridae: second report. Intervirology (1978) 2.05
Identification of HHR23A as a substrate for E6-associated protein-mediated ubiquitination. J Biol Chem (1999) 2.02
A cohort study of health care workers to assess nosocomial transmissibility of Nipah virus, Malaysia, 1999. J Infect Dis (2001) 2.02
Apnea associated with respiratory syncytial virus infection in young infants. J Pediatr (1977) 2.00
Myocardial iron loading in patients with thalassemia major on deferoxamine chelation. J Cardiovasc Magn Reson (2006) 1.97
In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain cross-reactivity. Proc Natl Acad Sci U S A (1994) 1.93
Cardiac structure and function in children with human immunodeficiency virus infection treated with zidovudine. N Engl J Med (1992) 1.92
Identification of a linear heparin binding domain for human respiratory syncytial virus attachment glycoprotein G. J Virol (1999) 1.91
Chlamydial infection of mothers and their infants. J Pediatr (1979) 1.89
Summary of a workshop on new and useful methods in viral diagnosis. J Infect Dis (1978) 1.87
Adenoviruses from patients with AIDS: a plethora of serotypes and a description of five new serotypes of subgenus D (types 43-47). J Infect Dis (1988) 1.87
Absence of cardiac toxicity of zidovudine in infants. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study Group. N Engl J Med (2000) 1.87
Microneutralization test for respiratory syncytial virus based on an enzyme immunoassay. J Clin Microbiol (1985) 1.84
Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked immunospot assay. J Virol (2000) 1.84
Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1beta. Nature (1997) 1.83
Growth in suckling-mouse brain of "IBV-like" viruses from patients with upper respiratory tract disease. Proc Natl Acad Sci U S A (1967) 1.82
Role of infection in chronic bronchitis. Am Rev Respir Dis (1976) 1.81
Early detection of human immunodeficiency virus on dried blood spot specimens: sensitivity across serial specimens. Women and Infants Transmission Study Group. J Pediatr (1996) 1.79
Tissue Doppler echocardiography in patients with thalassaemia detects early myocardial dysfunction related to myocardial iron overload. Eur Heart J (2003) 1.79
Occupational risk of human parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiosum. JAMA (1990) 1.79
Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children. J Virol (2000) 1.79
Monoclonal antibodies to respiratory syncytial virus: detection of virus neutralization and other antigen-antibody systems using infected human and murine cells. J Virol Methods (1981) 1.78
Respiratory syncytial virus detection by immunofluorescence in nasal secretions with monoclonal antibodies against selected surface and internal proteins. J Clin Microbiol (1983) 1.78
Bronchiolitis-associated hospitalizations among American Indian and Alaska Native children. Pediatr Infect Dis J (2000) 1.75
Analyses of homologous rotavirus infection in the mouse model. Virology (1995) 1.75
The neural correlates of fatigue: an exploratory imaginal fatigue provocation study in chronic fatigue syndrome. Psychol Med (2008) 1.72
Simultaneous detection and identification of human parainfluenza viruses 1, 2, and 3 from clinical samples by multiplex PCR. J Clin Microbiol (1998) 1.71
Respiratory syncytial virus G and/or SH protein alters Th1 cytokines, natural killer cells, and neutrophils responding to pulmonary infection in BALB/c mice. J Virol (1999) 1.71
Antibody-mediated enhancement of respiratory syncytial virus infection in two monocyte/macrophage cell lines. J Infect Dis (1989) 1.70
Cell-free and cell-bound antibody in nasal secretions from infants with respiratory syncytial virus infection. Infect Immun (1979) 1.70
Pediatric hospitalizations for croup (laryngotracheobronchitis): biennial increases associated with human parainfluenza virus 1 epidemics. J Infect Dis (1997) 1.69
Human rabies in the United States, 1960 to 1979: epidemiology, diagnosis, and prevention. Ann Intern Med (1984) 1.68
Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus. J Clin Microbiol (1991) 1.68
Seroepidemiologic studies of coronavirus infection in adults and children. Am J Epidemiol (1970) 1.66
Cardiogenic shock complicating acute myocardial infarction--etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol (2000) 1.66
Rotavirus as a cause of diarrheal morbidity and mortality in the United States. J Infect Dis (1988) 1.65
Neonatal Haemophilus influenzae infection. Report of eight cases and review of the literature. Am J Dis Child (1975) 1.65
Cardiac morbidity and related mortality in children with HIV infection. JAMA (1993) 1.65
Bending-related faulting and mantle serpentinization at the Middle America trench. Nature (2003) 1.64
The stabilization and purification of respiratory syncytial virus using MgSO4. Virology (1980) 1.63
Interferon in nasal secretions from infants with viral respiratory tract infections. J Pediatr (1978) 1.61
V3 region polymorphisms in HIV-1 from Brazil: prevalence of subtype B strains divergent from North American/European prototype and detection of subtype F. AIDS Res Hum Retroviruses (1994) 1.59
Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics. J Clin Microbiol (1998) 1.58
Postexposure trial of a human diploid cell strain rabies vaccine. J Infect Dis (1980) 1.58
Is it time to give influenza vaccine to healthy infants? N Engl J Med (2000) 1.58
Management and outcomes of pregnancies complicated by human B19 parvovirus infection: a prospective study. Am J Obstet Gynecol (1990) 1.58
Molecular characterization of a nosocomial outbreak of human respiratory syncytial virus on an adult leukemia/lymphoma ward. J Infect Dis (1999) 1.57